ALTERITY THERAPEUTICS LTD
For the period ended Oct 31, 2026. Filed Oct 19, 2026.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Oct 31, 2026 · Filed Oct 19, 2026
Use the contents to explore the available documents and sections.
ATHE$2.43+9.5%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · Authorisation & Additional information
Authorisation & Additional information
This announcement was authorized by David Stamler, CEO of Alterity Therapeutics Limited.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.